Daniel Goldberger Sells 80,000 Shares of electroCore (NASDAQ:ECOR) Stock

by · The Cerbat Gem

electroCore, Inc. (NASDAQ:ECOR – Get Free Report) Director Daniel Goldberger sold 80,000 shares of the firm’s stock in a transaction dated Thursday, April 23rd. The stock was sold at an average price of $6.80, for a total transaction of $544,000.00. Following the sale, the director owned 211,471 shares of the company’s stock, valued at $1,438,002.80. This trade represents a 27.45% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.

electroCore Stock Performance

ECOR traded up $0.07 during midday trading on Friday, reaching $10.25. The company had a trading volume of 153,518 shares, compared to its average volume of 88,040. electroCore, Inc. has a 12-month low of $4.16 and a 12-month high of $10.45. The business has a 50-day moving average price of $7.24 and a two-hundred day moving average price of $6.37. The stock has a market cap of $85.08 million, a PE ratio of -5.79 and a beta of 0.83.

electroCore (NASDAQ:ECOR – Get Free Report) last released its earnings results on Wednesday, May 6th. The company reported ($0.59) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.59). electroCore had a negative net margin of 44.08% and a negative return on equity of 1,956.38%. The firm had revenue of $9.58 million during the quarter, compared to the consensus estimate of $9.01 million. On average, research analysts anticipate that electroCore, Inc. will post -1.48 earnings per share for the current year.

Analysts Set New Price Targets

A number of research firms have issued reports on ECOR. Weiss Ratings reissued a “sell (d-)” rating on shares of electroCore in a research report on Friday, March 27th. Zacks Research upgraded electroCore from a “strong sell” rating to a “hold” rating in a research note on Friday, March 27th. One analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $18.00.

Get Our Latest Stock Analysis on electroCore

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of the business. NewEdge Advisors LLC lifted its position in shares of electroCore by 857.9% during the first quarter. NewEdge Advisors LLC now owns 161,955 shares of the company’s stock worth $1,083,000 after acquiring an additional 145,047 shares in the last quarter. Tejara Capital Ltd purchased a new position in shares of electroCore in the fourth quarter valued at $450,000. International Assets Investment Management LLC grew its position in shares of electroCore by 15.2% in the fourth quarter. International Assets Investment Management LLC now owns 88,720 shares of the company’s stock valued at $398,000 after purchasing an additional 11,700 shares in the last quarter. DRW Securities LLC bought a new stake in shares of electroCore during the 4th quarter valued at $264,000. Finally, Jaffetilchin Investment Partners LLC lifted its holdings in electroCore by 7.4% during the 4th quarter. Jaffetilchin Investment Partners LLC now owns 52,363 shares of the company’s stock worth $235,000 after purchasing an additional 3,600 shares in the last quarter. 26.74% of the stock is currently owned by hedge funds and other institutional investors.

electroCore Company Profile

(Get Free Report)

electroCore, Inc is a commercial-stage bioelectronic medicine company headquartered in Rockaway, New Jersey. The company specializes in the development and commercialization of non-invasive vagus nerve stimulation (nVNS) therapies designed to address a variety of neurological and inflammatory conditions. Established in 2006, electroCore has focused its efforts on translating neuromodulation science into a compact, patient-administered treatment device.

The company’s lead product, gammaCore®, is a handheld, battery-powered device that delivers nVNS through the skin to the cervical branch of the vagus nerve.

Featured Articles